[Glycosylation of autoantibodies in autoimmunes diseases]

Rev Med Interne. 2013 Dec;34(12):746-53. doi: 10.1016/j.revmed.2013.09.005. Epub 2013 Oct 16.
[Article in French]

Abstract

Protein glycosylation is one of the most common post-translational modifications, involved in the well described protein biosynthesis process. Protein glycosylation seems to play a major role in the pathogenesis of auto-immune diseases. Herein are described the main alterations of autoantibody glycosylation associated with autoimmunes diseases such as rheumatoid arthritis, IgA glomerulonephritis, Schoenlein-Henoch purpura, Sjögren's syndrome, systemic scleroderma, systemic lupus erythematosus, myasthenia gravis and granulomatosis with polyangiitis (Wegener). Molecular identification of altered immunoglobulin glycosylation could lead to a better understanding of the pathogenesis of those diseases, might allow an evaluation of their biological activity and could even be a new therapeutic target.

Keywords: Auto-anticorps; Autoantibodies; Autoimmune diseases; Glycosylation; Immunoglobulines; Immunoglobulins; Maladies auto-immunes; Sialylation.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Animals
  • Autoantibodies / metabolism*
  • Autoimmune Diseases / immunology
  • Autoimmune Diseases / metabolism*
  • Autoimmune Diseases / therapy
  • Epitopes / metabolism
  • Glycosylation
  • Granulomatosis with Polyangiitis / immunology
  • Granulomatosis with Polyangiitis / metabolism
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use
  • Immunomodulation

Substances

  • Autoantibodies
  • Epitopes
  • Immunoglobulins, Intravenous